July 6, 2025 - 18:31

There was drama during the first set of Sonay Kartal's round of 16 clash with Anastasia Pavlyuchenkova at Wimbledon on Sunday as the electronic line calling system failed. The much-anticipated match took a surprising turn when a crucial point was marred by a malfunction in the AI line judge, leading to confusion among players and spectators alike.
As Kartal and Pavlyuchenkova battled fiercely for supremacy on Centre Court, the unexpected error from the electronic system resulted in a disputed call that left both athletes visibly frustrated. The incident sparked a heated debate about the reliability of technology in high-stakes sports, particularly in a prestigious tournament like Wimbledon.
Fans and analysts expressed their concerns regarding the implications of such errors on the outcome of matches. While the players attempted to maintain their focus amidst the chaos, the incident served as a reminder of the challenges that come with integrating technology into traditional sports. The match continued, but the shadow of the AI blunder lingered over the proceedings.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...